skip to content
Bladder Cancer
Risk factors for bladder cancers include age, use of tobacco, occupation, infections, drug therapy for other cancers, race, being male, family history and personal history.
Symptoms of bladder cancer include blood in the urine, pain during urination and frequent urination, or a feeling of needing to urinate without results.
Follow the links below to find information on bladder cancer.
Reviewed October 2011
14 Resources Found
Results 1 to 14 displayed.
| Title: | New drugs - Vinflunine |
|---|---|
| Publisher: | Australian Prescriber |
| Description: | Some of the views expressed in the following notes on newly approved products should be regarded as tentative, as there may have been limited published data and little experience in Australia of their safety or efficacy. |
| Date: | Aug 2011 |
| Title: | Pioglitazone and risk of bladder cancer |
|---|---|
| Publisher: | HealthInsite Editorial Team |
| Description: | The Therapeutic Goods Administration (TGA) is advising health professionals and consumers that use of the diabetes medicine, pioglitazone, for more than a year may be associated with an increased risk of bladder cancer. |
| Date: | Jul 2011 |
| Title: | Pioglitazone and risk of bladder cancer |
|---|---|
| Publisher: | Australian Government Department of Health and Ageing |
| Description: | The TGA is advising health professionals and consumers that use of the diabetes medicine, pioglitazone, for more than a year may be associated with an increased risk of bladder cancer |
| Date: | Jul 2011 |
| Title: | Bladder cancer |
|---|---|
| Publisher: | Better Health Channel |
| Description: | Bladder cancer can have symptoms including blood in the urine (wee) and a painful burning sensation on urination. Cigarette smoking is the most significant risk factor for bladder cancer. |
| Date: | Jun 2011 |
| Title: | Staging of bladder cancer |
|---|---|
| Publisher: | Department of Health Western Australia |
| Description: | This pathway provides a diagnostic imaging algorithm for staging of patients with bladder cancer on histology. |
| Date: | Jun 2011 |
| Title: | Bladder cancer |
|---|---|
| Publisher: | The Cancer Council Victoria |
| Description: | Learn more about bladder cancer, including treatment, testing, nutrition, support available, and more. |
| Date: | May 2011 |
| Title: | Bladder Cancer (Transitional cell carcinoma of the Bladder) |
|---|---|
| Publisher: | Virtual Medical Centre.com |
| Description: | Information on the symptoms, treatment and diagnosis of bladder cancer by professional health specialists. |
| Date: | Feb 2011 |
| Title: | Gemcitabine for unresectable, locally advanced or metastatic bladder cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | When bladder cancer has spread beyond the bladder and is unresectable or metastatic, the possibility of cure is severely diminished. Treatment at this stage of the disease aims to reduce the disease-related symptoms and to improve quality of life. Chemo... |
| Date: | Jul 2010 |
| Title: | Bladder cancer (squamous cell carcinoma of the bladder) |
|---|---|
| Publisher: | Virtual Medical Centre.com |
| Description: | Squamous cell carcinoma of the bladder is a rarer type of bladder cancer. Provides information on the symptoms, diagnosis and treatment of the disease. |
| Date: | Jan 2009 |
| Title: | Intravesical BCG (bacillus Calmette-Guerin vaccine for immunotherapy) |
|---|---|
| Publisher: | Virtual Medical Centre.com |
| Description: | Intravesical (within the bladder) BCG is one of the most commonly used immunotherapies used in bladder cancer treatment. Bacillus Calmette-Guerin (BCG) is the vaccination used to protect against tuberculosis (TB), yet when administered into the bladder is thought to provoke an immune response. |
| Date: | May 2008 |
| Title: | Bladder cancer |
|---|---|
| Publisher: | Better Health Channel |
| Description: | A cross-section of the bladder showing a cancerous growth developing on the wall of the bladderand invading the bladder wall. |
| Date: | Aug 2003 |
| Title: | Intravesical Bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Men and women who have initially been treated with surgical removal the bladder lining containing cancer (transurethral resection of the bladder) for Ta (cancer that is contained within the tissue lining of the bladder) and T1 (more invasive but not int... |
| Date: | Apr 2003 |
| Title: | Surgery versus radiotherapy for muscle invasive bladder cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Bladder cancer is common worldwide. In rare cases, cancer spreads to the bladder muscle. A combination of surgery and radiation therapy (radiotherapy) is used to try to treat bladder cancer that has invaded the muscle. One treatment involves some radiot... |
| Date: | Aug 2001 |
| Title: | Intravesical Bacillus Calmette-Guerin in Ta and T1 bladder cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Worldwide, bladder cancer is common in both men and women. In most cases, the cancer occurs in the superficial layers of the bladder and can be surgically removed. However, in many people the cancer returns. Drugs placed directly into the bladder tissue... |
| Date: | Jul 2000 |
Results 1 to 14 displayed.
